Mexico and Canada 
Outside North America 
US 
CAT #: 43100100
Proficiency Panel for the BCR/ABL t(9;22) Translocation Assay
Product Use
Invivoscribe’s RNA Controls and Panels are intended for validation by the end user for use in molecular assays. These controls are specific to gene rearrangements, mutations, and/or translocations from human RNA.
Product Details
-
Description
This 10 member panels consists of 100% clonal control RNA extracted from three BCR/ABL positive cell lines as well as 10-2 (1:100) and 10-4 (1:10,000) dilutions (v/v) of these positive RNAs diluted into a normal (BCR/ABL negative) control RNA, IVS-0035 Clonal Control RNA. A sample of 100% IVS-0035 Clonal Control RNA is also included. All three cell lines (IVS-0003, IVS-0011, and IVS-0032) carry a t(9;22) translocation. One of the cell lines, IVS-0032, encodes for p190-type (ALL-associated) transcripts with e1a2 junctions. The other two cell lines both encode for p210-type (CML-associated) transcripts. One of the p210-type translocations, IVS-0003, harbors a b2a2 junction and the other, IVS-0011, harbors a b3a2 junction. This proficiency panel is used to validate tests that identify BCR/ABL t(9;22) translocations and is designed to be used with the BCR/ABL t(9;22) Translocation Assay Kits.
Legal Notice
Warranty and Liability
Invivoscribe, Inc. (Invivoscribe®) is committed to providing the highest quality products. Invivoscribe® warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert.If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe®. Invivoscribe® liability shall not exceed the purchase price of the product.Invivoscribe shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchaser’s laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of internally validated positive, negative, and blank controls every time a sample is tested. Ordering, acceptance and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.
This product is for Research Use Only; not for use in diagnostic procedures.
©2020 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe, Inc. and/or its affiliates, or (as to the trademarks of others used herein) their respective owners.